These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 22215715)

  • 1. Asymmetric dimethylarginine and reactive oxygen species: unwelcome twin visitors to the cardiovascular and kidney disease tables.
    Wilcox CS
    Hypertension; 2012 Feb; 59(2):375-81. PubMed ID: 22215715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin II and NADPH oxidase increase ADMA in vascular smooth muscle cells.
    Luo Z; Teerlink T; Griendling K; Aslam S; Welch WJ; Wilcox CS
    Hypertension; 2010 Sep; 56(3):498-504. PubMed ID: 20696982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impaired endothelial function and microvascular asymmetrical dimethylarginine in angiotensin II-infused rats: effects of tempol.
    Wang D; Luo Z; Wang X; Jose PA; Falck JR; Welch WJ; Aslam S; Teerlink T; Wilcox CS
    Hypertension; 2010 Nov; 56(5):950-5. PubMed ID: 20837884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Asymmetric dimethylarginine: predictor of cardiovascular diseases?].
    Németh B; Kustán P; Németh Á; Lenkey Z; Cziráki A; Kiss I; Sulyok E; Ajtay Z
    Orv Hetil; 2016 Mar; 157(13):483-7. PubMed ID: 26996894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Asymmetric dimethylarginine reduces nitric oxide donor-mediated dilation of arterioles by activating the vascular renin-angiotensin system and reactive oxygen species.
    Veresh Z; Debreczeni B; Hamar J; Kaminski PM; Wolin MS; Koller A
    J Vasc Res; 2012; 49(4):363-72. PubMed ID: 22652896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Asymmetric Dimethylarginine Limits the Efficacy of Simvastatin Activating Endothelial Nitric Oxide Synthase.
    Hsu CP; Zhao JF; Lin SJ; Shyue SK; Guo BC; Lu TM; Lee TS
    J Am Heart Assoc; 2016 Apr; 5(4):e003327. PubMed ID: 27091343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteinuria elevates asymmetric dimethylarginine levels via protein arginine methyltransferase-1 overexpression in a rat model of nephrotic syndrome.
    Kaida Y; Ueda S; Yamagishi S; Nakayama Y; Ando R; Iwatani R; Fukami K; Okuda S
    Life Sci; 2012 Sep; 91(9-10):301-5. PubMed ID: 22749861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nitric oxide synthase inhibition and oxidative stress in cardiovascular diseases: possible therapeutic targets?
    Rochette L; Lorin J; Zeller M; Guilland JC; Lorgis L; Cottin Y; Vergely C
    Pharmacol Ther; 2013 Dec; 140(3):239-57. PubMed ID: 23859953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Asymmetric dimethylarginine reduced erythrocyte deformability in streptozotocin-induced diabetic rats.
    Yang ZC; Xia K; Wang L; Jia SJ; Li D; Zhang Z; Deng S; Zhang XH; Deng HW; Li YJ
    Microvasc Res; 2007 Mar; 73(2):131-6. PubMed ID: 17098259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Asymmetric dimethylarginine (ADMA): a potential link between endothelial dysfunction and cardiovascular diseases in insulin resistance syndrome?
    Chan NN; Chan JC
    Diabetologia; 2002 Dec; 45(12):1609-16. PubMed ID: 12488950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dimethylarginine dimethylaminohydrolase (DDAH): expression, regulation, and function in the cardiovascular and renal systems.
    Palm F; Onozato ML; Luo Z; Wilcox CS
    Am J Physiol Heart Circ Physiol; 2007 Dec; 293(6):H3227-45. PubMed ID: 17933965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lysophosphatidylcholine-induced elevation of asymmetric dimethylarginine level by the NADPH oxidase pathway in endothelial cells.
    Jia SJ; Jiang DJ; Hu CP; Zhang XH; Deng HW; Li YJ
    Vascul Pharmacol; 2006 Mar; 44(3):143-8. PubMed ID: 16309971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Asymmetric dimethylarginine (ADMA) is a novel emerging risk factor for cardiovascular disease and the development of renal injury in chronic kidney disease.
    Ueda S; Yamagishi SI; Matsumoto Y; Fukami K; Okuda S
    Clin Exp Nephrol; 2007 Jun; 11(2):115-121. PubMed ID: 17593510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of dimethylarginine dimethylaminohydrolase inhibits asymmetric dimethylarginine-induced endothelial dysfunction in the cerebral circulation.
    Dayoub H; Rodionov RN; Lynch C; Cooke JP; Arning E; Bottiglieri T; Lentz SR; Faraci FM
    Stroke; 2008 Jan; 39(1):180-4. PubMed ID: 18063827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The determinants of endothelial dysfunction in CKD: oxidative stress and asymmetric dimethylarginine.
    Yilmaz MI; Saglam M; Caglar K; Cakir E; Sonmez A; Ozgurtas T; Aydin A; Eyileten T; Ozcan O; Acikel C; Tasar M; Genctoy G; Erbil K; Vural A; Zoccali C
    Am J Kidney Dis; 2006 Jan; 47(1):42-50. PubMed ID: 16377384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nephroprotective effects of nebivolol in 2K1C rats through regulation of the kidney ROS-ADMA-NO pathway.
    Wang Y; Niu M; Yin S; Zhang F; Shi R
    Pharmacol Rep; 2018 Oct; 70(5):917-929. PubMed ID: 30099298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Asymmetric dimethylarginine--a novel cardiovascular risk factor].
    Siroká R; Cibulka R; Rajdl D; Racek J
    Vnitr Lek; 2006 Mar; 52(3):249-55. PubMed ID: 16722156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Roles of oxidants, nitric oxide, and asymmetric dimethylarginine in endothelial function.
    Siekmeier R; Grammer T; März W
    J Cardiovasc Pharmacol Ther; 2008 Dec; 13(4):279-97. PubMed ID: 18945874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Asymmetric dimethylarginine: a cardiovascular risk factor in renal disease?
    Fliser D; Kielstein JT; Haller H; Bode-Böger SM
    Kidney Int Suppl; 2003 May; (84):S37-40. PubMed ID: 12694305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Asymmetric dimethylarginine (ADMA), symmetric dimethylarginine (SDMA) and homoarginine (hArg): the ADMA, SDMA and hArg paradoxes.
    Tsikas D; Bollenbach A; Hanff E; Kayacelebi AA
    Cardiovasc Diabetol; 2018 Jan; 17(1):1. PubMed ID: 29301528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.